Ann Child Neurol.  2024 Jul;32(3):143-153. 10.26815/acn.2024.00437.

Reversible Cerebral Vasoconstriction Syndrome in Children and Adolescents: A Case Series and Literature Review

Affiliations
  • 1Department of Pediatrics, Chungnam National University College of Medicine, Daejeon, Korea
  • 2Department of Public Health, School of Public Health, University of Zambia, Lusaka, Zambia
  • 3Department of Pediatrics, Chungnam National University Hospital, Daejeon, Korea
  • 4Department of Pediatrics & Medical Science, Brain Research Institute, Chungnam National University College of Medicine, Daejeon, Korea

Abstract

Reversible cerebral vasoconstriction syndrome (RCVS) is a clinical radiographic phenomenon characterized by thunderclap headaches and transient vasoconstriction of cerebral vessels, which typically resolve within 3 months of symptom onset. Although RCVS has been extensively studied in adults, research on this condition in pediatric populations is limited, likely due to its perceived rarity. This comprehensive review aims to bridge the knowledge gap by examining the clinical presentation, diagnostic methods, treatment strategies, and prognostic outcomes of pediatric RCVS cases, including two case reports contributed by the authors. This study demonstrates an inconclusive sex distribution of RCVS in children, attributed to the scarcity of comprehensive studies of this demographic. Additionally, we identified several predictors of adverse neurological outcomes in children with RCVS, including motor deficits, aphasia, hypertension, and renal disease. This study offers a thorough overview of RCVS in the pediatric population, providing valuable insights to inform future research in this area.

Keyword

Vasospasm, intracranial; Headache disorders, primary; Migraine disorders; Cerebral angiography; Nimodipine
Full Text Links
  • ACN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr